Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition Post author: Post published:May 20, 2024 Post category:uncategorized Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models. You Might Also Like Catalonia study highlights unhealthy snack trends among school-aged children September 16, 2024 AI-enhanced mammography improves cancer detection in self-pay program December 6, 2024 £1.9M funding supports research into drivers of health disparities and associated infectious disease burden January 21, 2024
£1.9M funding supports research into drivers of health disparities and associated infectious disease burden January 21, 2024